Key facts
- It has raised $1.5M; the latest was Early Stage VC in Jan 2025.
- Notable investors include Wuxi Capital, Wuxi High-tech Zone Venture Capital Holding Group, YuanMing Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Brisight Nord
- ·The full record, as it builds
Funding rounds
No funding rounds for Brisight Nord are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Brisight Nord
Developer of mid- to high-end ophthalmic medical devices designed for patients with ophthalmic diseases. The company develops glass cutting machines, ultrasound machines, IOL and excimer lasers and also builds a sound and complete training service system, enabling patients to have high quality, high precision and high safety ophthalmic medical devices.
- Sector
- Healthcare
- HQ
- Wuxi, China
- Founded
- 2021
- Website
- jiashinuode.com/
- Ownership
- Privately Held (backing)
Brisight Nord doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Brisight Nord shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Brisight Nord in its N-PORT filings yet. We sweep new filings monthly.